Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21355097 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma
Conditions: Cutaneous T Cell Lymphoma;   Peripheral T Cell Lymphoma
Intervention: Drug: Romidepsin

Indicates status has not been verified in more than two years